We currently have no Breaking News on this stock.
There are no StockTalks on this stock yet.
We are a development-stage pharmaceutical company that develops therapeutics for the treatment of cancer. Our research and product development activities to date have consisted primarily of conducting preclinical trials of product candidates, obtaining regulatory approval for clinical trials,... More
Country: United States
Other News & PR